Stoke Therapeutics (STOK) Earnings Date & Reports

A.I. Advisor

published Earnings

STOK is expected to report earnings to rise 15.78% to -53 cents per share on November 13

Stoke Therapeutics STOK Stock Earnings Reports

Q3'24

Est.

$-0.53

Q2'24

Beat

by $0.09

Q1'24

Beat

by $0.05

Q4'23

Beat

by $0.04

Q3'23

Beat

by $0.08

The last earnings report on August 07 showed earnings per share of -46 cents, beating the estimate of -54 cents. With 331.47K shares outstanding, the current market capitalization sits at 797.61M.

View a ticker or compare two or three

Compare

STOK

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For STOK
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for STOK (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a company, which engages in the research and development of treatments for genetic diseases.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

45 Wiggins Avenue

Phone

+1 781 430-8200

Employees

110

Web

https://www.stoketherapeutics.com